Table 3.

Regression analysis

	Relapse	No relapse	Regression coefficient	Odds ratio	P value
Local relapse
Oestrogen receptor α
Positive	34	69	0.1132	1.12	0.787
Negative	11	25
Progesterone receptor
Positive	20	45	−0.138	0.87	0.705
Negative	25	49
HER2
Positive	13	27	0.008	1.008	0.984
Negative	32	67
STS
Positive	16	65	−1.367	0.255	<0.001
Negative	28	29
17βHSD2
Positive	41	72	1.429	4.176	0.027
Negative	3	22
Androgen receptor
Positive	40	77	0.955	2.59	0.149
Negative	3	15
Glucocorticoid receptor
Positive	23	45	0.346	1.413	0.365
Negative	17	47
Aromatase
Cont.			0.039	1.039	0.802
Oestrogen receptor β
Cont.			−0.002	0.998	0.304
Ki67
Cont.			−0.003	0.99	0.782
Distal relapse
Oestrogen receptor α
Positive	29	72	−0.034	0.9667	0.938
Negative	10	24
Progesterone receptor
Positive	19	46	0.03209	1.032	0.932
Negative	20	50
HER2
Positive	13	25	0.3507	1.42	0.394
Negative	25	71
STS
Positive	11	68	−1.7852	0.168	<0.001
Negative	27	28
17βHSD2
Positive	35	74	1.244	3.468	0.055
Negative	3	22
Androgen receptor
Positive	34	81	0.598	1.819	0.374
Negative	3	13
Glucocorticoid receptor
Positive	21	45	0.5647	1.759	0.167
Negative	13	49
Aromatase
Cont.			−0.065	0.937	0.680
Oestrogen receptor β
Cont.			−0.001	0.999	0.662
Ki67
Cont.			0.00342	1.033	0.756

Relationships between nuclear receptors, steroidogenic enzymes, and clinical outcome. Samples with a P value falling below 0.05 are given in italics